Maximus (MMS) drew investor attention after its fiscal 2026 third quarter results and updated guidance pointed to revenue near the lower end of expectations, while management flagged ongoing uncertainty from contract delays and weaker award conversion.

The earnings update and softer revenue guidance have coincided with weaker share price momentum for Maximus, with the stock down 35.17% year to date on a share price basis and the 5 year total shareholder return also in decline. This points to fading momentum as investors reassess contract and award conversion risks.

If this kind of mixed outlook has you reassessing your watchlist, it can help to widen the search beyond a single government services provider. Take a look at the 20 top founder-led companies

So, with Maximus under pressure and guidance pointing to the lower end of revenue expectations, does the current valuation still leave enough upside to justify taking on the contract and award conversion risks?

Most Popular Narrative: 43.9% Undervalued

Based on the most followed narrative, Maximus is trading well below an assessed fair value of $100, compared with the recent close around $56. This framing hinges on how future contract driven earnings and cash flows are expected to play out under that narrative.

Pending implementation of new federal legislation (e.g. Medicaid work requirements, increased eligibility reviews, and SNAP payment integrity) is set to significantly expand state demand for Maximus' compliance and administration services starting in FY27, positioning the company for an above-trend acceleration in organic revenue growth.

The narrative leans heavily on how far earnings, margins and future valuation multiples might shift if these policy and digital transformation drivers fully feed through. You may want to examine which revenue mix, margin path and future earnings multiple would need to align to support that $100 fair value tag.

Result: Fair Value of $100 (UNDERVALUED)

However, this Maximus narrative also relies on timely legislation-driven contract rollouts and assumes government clients do not accelerate insourcing or shift volumes to competitors.

Next Steps

With mixed sentiment around Maximus, you can move quickly to weigh the concerns and potential upside yourself by reviewing the 5 key rewards and 1 important warning sign

Looking for more investment ideas beyond Maximus?

If Maximus has you rethinking your portfolio, do not stop at one stock. Broaden your opportunity set now so you are not reacting after the next move.

• Target steady potential by reviewing companies focused on reliable shareholder returns through the 11 dividend fortresses
• Hunt for mispriced opportunities where quality and valuation may still line up using the 51 high quality undervalued stocks
• Strengthen your watchlist with companies that pair financial resilience with healthy balance sheets via the solid balance sheet and fundamentals stocks screener (49 results)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.